Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis and behavior.

James B Pinkston1, Anita Kablinger, Nadejda Alekseeva

  • 1Department of Neurology, Louisiana State University Medical Center, Shreveport, Louisiana 71103, USA.

International Review of Neurobiology
|May 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Episodic Future Thinking as an Intervention for Alcohol Use Disorder: Effects on Delay Discounting and Real-World Alcohol Consumption.

Research square·2026
Same author

Prevalence of pediatric cannabidiol prescribing in the United States.

World journal of pediatrics : WJP·2026
Same author

Association Between Impulsivity, Self-Harm, Suicidal Ideation, and Suicide Attempts in Patients with Traumatic Brain Injury.

Journal of neurotrauma·2024
Same author

Noninferiority Clinical Trial of Adapted START NOW Psychotherapy for Outpatient Opioid Treatment.

Research square·2023
Same author

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium.

General hospital psychiatry·2023
Same author

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
See all related articles

Multiple sclerosis (MS) significantly impacts cognitive and psychiatric health, affecting quality of life. This review details MS behavioral symptoms, including cognitive deficits and mood disorders.

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Multiple sclerosis (MS) is a leading cause of neurological disability in adults.
  • MS affects cognition, psychiatric status, and quality of life, imposing significant burdens.

Purpose of the Study:

  • To review recent literature on the behavioral manifestations of Multiple Sclerosis.
  • To discuss cognitive and psychiatric symptoms, and their impact on quality of life.

Main Methods:

  • Literature review of recent studies on MS behavioral manifestations.
  • Analysis of cognitive domains: executive functioning, processing speed, attention, memory, language, and visual spatial processing.
  • Examination of psychiatric symptoms: depression, bipolar disorder, psychosis, and personality changes.

Main Results:

Related Experiment Videos

  • MS commonly impairs executive functioning, processing speed, and attention.
  • Psychiatric issues like depression and mood disturbances are prevalent in MS patients.
  • Quality of life is affected by fatigue, pain, sexual dysfunction, and cognitive decline.

Conclusions:

  • Behavioral changes, including cognitive and psychiatric symptoms, are integral to Multiple Sclerosis.
  • Understanding these manifestations is crucial for managing MS and improving patient outcomes.
  • Further research is needed on treatment effects and comprehensive care strategies.